After PHx, the uPA quantity remains relatively constant, but the uPA receptor (uPAR) dramatically increases after PHx, just beginning within 1 min
Patients suffering from major depression had reduced levels of immunoreactive DSIP compared to control subjects, as shown in cerebrospinal fluid (CSF) analysis
Research-use-only laboratory material Lyophilized research peptide listed for tissue-pathway laboratory catalogs

BPC-157: Best for nerve regeneration and pain Why it helps nerve pain: Promotes nerve regeneration Reduces nerve inflammation Protects nerves from further damage Improves nerve function Best for: Diabetic neuropathy Post-injury nerve pain Sciatica (nerve compression pain) Peripheral neuropathy Nerve damage from surgery Dosing: 250-500mcg twice daily Injectable systemic (abdomen or thighs) 8-16 weeks minimum Nerve healing is slow - be patient Timeline: Week 2-4: Slight pain reduction Week 6-8: Noticeable improvement Week 12-16: Significant pain relief May need 6+ months for severe neuropathy KPV: Alternative for inflammatory nerve pain Why KPV works: Potent anti-inflammatory Reduces inflammatory cytokines affecting nerves Calms immune system response Good for autoimmune-related nerve pain Best for: Inflammatory neuropathy Autoimmune nerve damage When inflammation is primary cause Dosing: 500-1,000mcg daily injectable Or oral for systemic inflammation 8-12 weeks See our KPV peptide dosage guide and KPV peptide benefits

An advisory committee to the Food and Drug Administration voted yesterday to recommend that compounding pharmacies be allowed to make the peptide, even though it has little human-safety data and hasnt passed through the normal FDA drug-approval process
The most important factor is bioavailability